Harvard Bioscience (HBIO) Non-cash Items (2019 - 2024)

Harvard Bioscience (HBIO) reported Non-cash Items of $91000.0 for Q2 2024, down 90.56% on a QoQ basis from $964000.0 in Q1 2024.

Harvard Bioscience (HBIO) has 6 years of Non-cash Items data on file, last reported at $91000.0 in Q2 2024.

Quarterly Non-cash Items changed N/A year-over-year to $91000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $91000.0 (changed N/A YoY) and the FY2023 annual result came in at $1.8 million, up 866.32% from the prior year.
Non-cash Items declined to $91000.0 in Q2 2024 per HBIO's latest filing, from $964000.0 in the prior quarter.
Across five years, Non-cash Items topped out at $5.6 million in Q4 2021 and bottomed at $91000.0 in Q2 2024.
The 5-year median for Non-cash Items is $1.4 million (2023), against an average of $1.9 million.
The widest annual swing landed in 2020, when Non-cash Items jumped 870.04%; it then slumped 96.58% in 2022.
Tracing HBIO's Non-cash Items over 5 years: stood at $2.5 million in 2020, then surged by 122.74% to $5.6 million in 2021, then tumbled by 96.58% to $190000.0 in 2022, then surged by 866.32% to $1.8 million in 2023, then sank by 95.04% to $91000.0 in 2024.
Per Business Quant, the three latest HBIO Non-cash Items figures stand at $91000.0 (Q2 2024), $964000.0 (Q1 2024), and $1.8 million (Q4 2023).

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	156.17 Bn	151.78 Bn	1.83 Bn
2	Becton Dickinson	41.51 Bn	40.49 Bn	2.15 Bn
3	Resmed	30.43 Bn	28.77 Bn	890.98 Mn
4	West Pharmaceutical Services	22.78 Bn	22.26 Bn	296.40 Mn
5	Solventum	13.39 Bn	13.39 Bn	1.10 Bn
6	Cooper Companies	12.33 Bn	12.20 Bn	695.20 Mn
7	Align Technology	11.65 Bn	10.59 Bn	736.59 Mn
8	Baxter International	9.81 Bn	7.77 Bn	891.00 Mn
9	Aptargroup	7.39 Bn	7.19 Bn	351.91 Mn
10	Harvard Bioscience	25.38 Mn	18.29 Mn	12.24 Mn

Download Data 🔒